SWOT Analysis Reports & Company Profiles

Publications found: 164,030
Sort by:

Stemline Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemline Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tetraphase Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tetraphase Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VBI Vaccines Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VBI Vaccines Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Checkpoint Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Checkpoint Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intellia Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intellia Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aralez Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aralez Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MacroGenics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MacroGenics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NewLink Genetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NewLink Genetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TherapeuticsMD Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TherapeuticsMD Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Five Prime Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Five Prime Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Endocyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Endocyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pacira BioSciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pacira BioSciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sarepta Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sarepta Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

K2M Group Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

K2M Group Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Merus BV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merus BV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Myos Rens Technology Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myos Rens Technology Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Portola Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Portola Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BOD Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BOD Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dimerix Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dimerix Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Noxopharm Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Noxopharm Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vectus Biosystems Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vectus Biosystems Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Paradigm Biopharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Paradigm Biopharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ultracharge Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ultracharge Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Black Star Petroleum Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Black Star Petroleum Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sienna Cancer Diagnostics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sienna Cancer Diagnostics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Zelda Therapeutics Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Zelda Therapeutics Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amplia Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amplia Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Race Oncology Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Race Oncology Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Stemcell United Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemcell United Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Manalto Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Manalto Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regeneus Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regeneus Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Invion Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Invion Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioxyne Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioxyne Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Smart Marine Systems Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Smart Marine Systems Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MGC Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MGC Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tempo Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tempo Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Recce Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recce Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BTC Health Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BTC Health Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

dorsaVi Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

dorsaVi Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orthocell Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orthocell Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anatara Lifesciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anatara Lifesciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Medlab Clinical Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medlab Clinical Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Invitrocue Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Invitrocue Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Auscann Group Holdings Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Auscann Group Holdings Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proteomics International Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteomics International Laboratories Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Resapp Health Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Resapp Health Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ephraim Resources Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ephraim Resources Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clinuvel Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clinuvel Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vita Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vita Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pharmally International Holding Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pharmally International Holding Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

7,665
6,761
4,993
4,645
4,328
4,036
3,979
3,241
3,083
2,925
2,713
2,595
2,125
2,024
2,008
1,654
1,587
1,254
1,158
1,091
982
791
789
572
494
493
304
1,542
9,254
3,983
67,744
8,589
1,186
3,442

Publishers

53,883
43,113
1,245
3
12
1
5
4
2
2
9
11,951
6
5
12,341
6
3
11,044
12
27
48
6
356
24,220
1
1,042
7
1
1,225
1,830
3
149
352
4
2
2
517
1
60

Regions

171
94
91
91
83
80
54
43
34
32
30
19
18
17
13
12
12
12
11
6
5
5
5
5
4
4
4
4
4
4
3
2
2
2
2
2
2
2
1
470
3
1
1
1
4,304
584
433
18
12
121
9
20
12
1
66
7
1
1,007
32
19
38
40
1
154
20
506
178
28,201
65
240
189
30
630
191
163
299
18
413
48
1,433
634
14
100
23
1,445
1
32
398
1
35
41
322
217
19
23
440
8
1
10
355
671
465
429
3,775
925
8,253
1,134
3
2,843
1,162
4
1
2
3,375
1,390
996
272
798
695
402
2,433
1,099
9,272
120
1,012
4,876
884
503
2
1,712
87
2
167
16
8,662
1,193
80
5,494
313
2,376
707
135
1
4
12
3
42,543
7,541

Price

—

Date

—

Pages

—

Offers